An Open Label, Safety Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS Topical Product in Patients With Plaque Psoriasis
Phase of Trial: Phase II/III
Latest Information Update: 25 May 2018
At a glance
- Drugs Desoximetasone (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Taro Pharmaceuticals USA
- 17 May 2018 Status changed from recruiting to completed.
- 16 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Dec 2018.
- 16 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.